12
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27093 |
CT-1
CT 1 |
p53 | Apoptosis |
CT-1 是一种 DNA 小沟配体,可导致 p53 依赖性乳腺癌细胞凋亡。 | |||
T62822 |
CT1-3
|
||
CT1-3 是一种有效的抗癌剂。CT1-3 能够调控 JNK/Bcl-2/Bax/XIAP 通路,进而诱导线粒体介导的细胞凋亡 (apoptosis)。CT1-3 可以调控 E-cadherin/Snail 轴抑制人癌细胞 (HCCs) 的上皮间充质转化 (EMT) 电位,并抑制肿瘤发生。CT1-3 在小鼠模型中具有抗肿瘤作用,且没有表现出明显的肝、肾毒性。 | |||
T14903 |
CCT129957
|
Calcium Channel; Phospholipase | Membrane transporter/Ion channel; Metabolism |
CCT129957 是一种新型有效的磷脂酶 C-γ (PLC-γ) 抑制剂,IC50 约为 3 μM,GC50 为 15 μM。CCT129957 具有抗癌活性,在鳞状细胞中抑制 Ca2+ 的释放。 | |||
T4133 |
CCT196969
|
Raf; Src | Angiogenesis; MAPK; Tyrosine Kinase/Adaptors |
CCT196969 是泛-Raf 抑制剂,抑制B-Raf、BRafV600E 和CRAF,IC50分别为 0.1、0.04、和 0.01 μM。 | |||
T6303L |
CCT128930 hydrochloride
CCT128930 hydrochloride(885499-61-6 Free base) |
Apoptosis; Akt; PKA; mTOR; Autophagy | Apoptosis; Autophagy; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
CCT128930 hydrochloride (CCT128930 hydrochloride) 是一种选择性 AKT 抑制剂,具有抗肿瘤活性。它通过靶向 AKT 的 Met282 (PKA-AKT 嵌合体的 Met173),对 PKA 激酶具有 28 倍的选择性,对 p70S6K 具有 20 倍的选择性。 | |||
T6435 |
CCT129202
2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺 |
Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic |
CCT129202 是一种 ATP 竞争性泛极光激酶抑制剂,作用于 Aurora A、Aurora B 和 Aurora C,IC50 分别为 0.042 μM、0.198 μM 和 0.227 μM。 | |||
T67727 |
MCT1-IN-3
|
Monocarboxylate transporter | Membrane transporter/Ion channel |
MCT1-IN-3是一种单羧酸转运蛋白1 (MCT1)抑制剂。溶质载体(SLC)单羧酸转运蛋白1 (MCT1);SLC16A1)是治疗癌症的一个有希望的靶点。MCT1-IN-3(化合物24)对MCT1转运抑制作用强,IC50值为81.0 nM。MCT1-IN-3对多药转运体ABCB1也有明显的抑制作用。 | |||
T6303 |
CCT128930
|
Akt; PKA; S6 Kinase; Autophagy | Autophagy; Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
CCT128930 是一种 ATP 竞争性,选择性 AKT 抑制剂。它通过靶向 AKT 的 Met282 (PKA-AKT 嵌合体的 Met173),对 PKA 激酶具有 28 倍的选择性,对 p70S6K 具有 20 倍的选择性,具有抗肿瘤活性。 | |||
T70400 |
CDK9/CycT1-IN-93
|
||
CDK9/CycT1-IN-93 is a highly specific, ATP-competitive inhibitor of CDK9/CycT1 with antiviral activity. | |||
T26221 |
MCT1-IN-2
SR13800,SR-13800,SR 13800 |
||
SR13800 is a monocarboxylate transporter 1 (MCT1) inhibitor with cell-permeable. | |||
T79187 |
CT1113
|
||
CT1113是一种针对USP28和USP25的高效抑制剂,能够在体内显著降低MYC水平,并在小鼠胰腺癌CDX模型中展示了其抗肿瘤活性。 | |||
T79904 |
PROTAC CDK9/CycT1 Degrader-2
|
CDK | Cell Cycle/Checkpoint |
PROTACCDK9/CycT1 Degrader-2 对CDK9表现出较高的抑制效能,具有一个IC50值为45 nM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-03917 |
Cardiotrophin 1 Protein, Human, Recombinant
cardiotrophin 1,CT-1,CT<... |
Human | HEK293 Cells |
Cardiotrophin 1 Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 21.2 kDa and the accession number is Q16619-1. | |||
TMPY-00398 |
Cardiotrophin 1 Protein, Human, Recombinant (hFc)
CT-1,CT1,cardiotrophin <... |
Human | HEK293 Cells |
Cardiotrophin 1 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.5 kDa and the accession number is Q16619-1. | |||
TMPJ-00086 |
CT-1 Protein, Human, Recombinant (His)
CTF1,CT-1,Cardiotrophin-... |
Human | E. coli |
Cardiotrophin-1, also known as CT-1 and CTF1, is a member of the IL-6 superfamily. It is a sreted cytokine that is expressed in heart, skeletal muscle, prostate and ovary, and to lower levels in lung, kidney, pancreas, thymus, testis and small intestine. The protein exerts its cellular effects by interacting with the glycoprotein 130 (gp130)/leukemia inhibitory factor receptor beta (LIFR) heterodimer. In addition, CT-1 activates phosphatidylinositol 3-kinase (PI-3 kinase) in cardiac myocytes and... | |||
TMPH-02151 |
OXCT1 Protein, Human, Recombinant (His)
|
Human | E. coli |
Key enzyme for ketone body catabolism. Transfers the CoA moiety from succinate to acetoacetate. Formation of the enzyme-CoA intermediate proceeds via an unstable anhydride species formed between the carboxylate groups of the enzyme and substrate. OXCT1 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 56.1 kDa and the accession number is P55809. | |||
TMPY-04316 |
LECT1 Protein, Human, Recombinant (hFc)
leukocyte cell derived chemotaxin 1,CHM-I,CHM1<... |
Human | HEK293 Cells |
LECT1 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 42.1 kDa and the accession number is O75829-2. |